MAXImune 800 Tablet

MAXImune 800 is commonly prescribed as an adjunct therapy in patients with chronic respiratory diseases such as chronic obstructive pulmonary disease (COPD), bronchitis, and recurrent upper respiratory tract infections to reduce the frequency and severity of infectious episodes. The tablet is administered orally, with dosage and duration tailored according to the patient’s clinical condition and physician’s discretion.

Clinical studies have demonstrated that Pidotimod improves immune parameters and reduces infection rates without significant adverse effects, making it a well-tolerated option for immune support. It is contraindicated in patients with hypersensitivity to the active ingredient or excipients. Caution is advised in autoimmune disorders due to its immunomodulatory properties. MAXImune 800 should be used under medical supervision to ensure optimal therapeutic outcomes.